Ospedale San Carlo di Nancy
Ospedale San Carlo di Nancy
Italy, Rome
Alessandro Calarco
19 anni di esperienza
Clinica certificata da :
Why do patients choose Italy for laparoscopic prostatectomy?
Access advanced Laparoscopic prostatectomy solutions in trusted clinics .
| Italy | Turchia | Austria | |
| Laparoscopic prostatectomy | - | da $7,500 | da $18,000 |
Revisionato medicalmente da
Fahad MawloodBookimed non aggiunge costi extra ai prezzi di Laparoscopic prostatectomy. Le tariffe provengono dai listini ufficiali delle cliniche. Pagherai direttamente in clinica per la tua Laparoscopic prostatectomy al tuo arrivo.
Bookimed si impegna per la tua sicurezza. Lavoriamo solo con strutture che mantengono elevati standard internazionali in Laparoscopic prostatectomy e hanno le licenze necessarie per servire pazienti internazionali in tutto il mondo.
Bookimed offre assistenza esperta gratuita. Un coordinatore medico personale ti supporta prima, durante e dopo il trattamento, risolvendo qualsiasi problema. Non sarai mai solo nel tuo percorso di Laparoscopic prostatectomy.
Day 1 - Arrival
Day 2 - Pre-Operation
Day 3 - Laparoscopic Prostatectomy
Day 4-7 - Post-Operation
Week 1-2 - Rehabilitation
Week 3-4
Week 5-6
Please note that each patient"s recovery time can vary based on individual health conditions and the complexity of the surgery.
Professor Luca Carmignani has performed over 10,000 surgeries, specializing in robotic laparoscopy and prostate treatments at Policlinico San Donato Research Hospital.
Dr. Alessandro Calarco is a skilled urologist with expertise in minimally invasive and endourological procedures. He performs percutaneous lithotripsy, ureterorenoscopy, tumor ablation, and advanced reconstructive surgeries. Dr. Calarco has received international recognition for his clinical work and research. He completed advanced training in Sweden and the UK.
Dr. Calarco graduated with top honors from Università Cattolica del Sacro Cuore in Rome. He completed his Urology specialization and earned a PhD in Oncological Urology at the same university. His research focuses on prostate cancer biomarkers and exosomes. He has also helped develop clinical protocols for hormone-refractory prostate cancer.
He serves as National Head of Urology for SPIGC and is a member of the European Board of Urology. Dr. Calarco holds an international patent for a device that improves percutaneous nephrolithotripsy. He has published extensively and received several awards for surgical innovation and education.
It is a minimally invasive procedure for removing the prostate gland, often used in prostate cancer treatment.